Option Care Health (NASDAQ:OPCH) Announces Quarterly Earnings Results, Hits Expectations

Option Care Health (NASDAQ:OPCH) released its quarterly earnings data on Wednesday. The company reported $0.49 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.49, FiscalAI reports. Option Care Health had a net margin of 3.74% and a return on equity of 19.06%. The firm had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same period last year, the business earned $0.45 earnings per share. Option Care Health’s revenue was up 4.1% compared to the same quarter last year.

Option Care Health Trading Down 0.5%

Shares of OPCH stock opened at $31.50 on Friday. Option Care Health has a 1-year low of $18.01 and a 1-year high of $36.80. The firm has a market cap of $4.72 billion, a PE ratio of 19.54, a price-to-earnings-growth ratio of 1.92 and a beta of 0.47. The company has a 50-day moving average of $27.14 and a two-hundred day moving average of $26.39. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.54 and a quick ratio of 0.98.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on OPCH shares. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and boosted their target price for the company from $28.00 to $32.05 in a report on Tuesday, October 6th. JPMorgan Chase & Co. downgraded shares of Option Care Health from an “overweight” rating to a “neutral” rating and set a $33.00 price target for the company. in a report on Wednesday, October 7th. Barrington Research lowered shares of Option Care Health from an “outperform” rating to a “hold” rating in a research report on Wednesday, October 7th. UBS Group cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $39.00 to $32.05 in a report on Friday, October 9th. Finally, Truist Financial set a $32.05 price objective on Option Care Health in a research report on Wednesday, October 7th. Two research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $29.48.

Option Care Health Company Profile

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.